Skip to content

Risk assessment of acute post-stroke limb spasticity and study on rehabilitation treatment with traditional Chinese medicine

Risk assessment of acute post-stroke limb spasticity and study on rehabilitation treatment with traditional Chinese medicine

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072437
Enrollment
Unknown
Registered
2023-06-13
Start date
2022-07-01
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Limb spasm after stroke

Interventions

normal group:rehabilitation therapy
treatment group:scalp acupuncture therapy combined with massage

Sponsors

The Third Affiliated Hospital of Changchun University of Chinese Medicine, Jilin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of Western medicine and Chinese medicine for stroke; 2. There are not symptoms of increased muscle tone of the limbs, and the modified Ashworth rating is 0; 3. The course of illness is within 1 months; 4. Aged 35-70 years; 5. Those who are conscious and have stable vital signs; 6. Patients or their family members sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Limb spasticity is existed; 2. Patients with severe primary diseases such as liver, kidney, hematopoietic system and endocrine system; 3. Those who have audiovisual abnormalities, severe cognitive impairment, or mental illness, who cannot cooperate with the examination and treatment; 4. Pregnant and lactating women; 5. Those who have not stable vital signs.

Design outcomes

Primary

MeasureTime frame
Modified Ashworth score;

Secondary

MeasureTime frame
Simplified Fugl-Meyer assessment scale;root mean square of Surface EMG;Modified Barthel index, MBI;National Institute of Health stroke scale;

Countries

China

Contacts

Public ContactGuangcheng Ji

The Third Affiliated Hospital of Changchun University of Chinese Medicine, Jilin

33452285@qq.com+86 188 4316 4081

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026